Markers of exacerbation severity in chronic obstructive pulmonary disease (Q34691221)

4 August 2017

0 references

Markers of exacerbation severity in chronic obstructive pulmonary disease (English)

1 reference

chronic obstructive pulmonary disease

4 August 2017

0 references

Clive P Page

2

0 references

Meindert Danhof

6

object named as

Meindert Danhof

1 reference

4 August 2017

Luigi G Franciosi

1

1 reference

4 August 2017

Bartolome R Celli

3

1 reference

4 August 2017

Mario Cazzola

4

1 reference

4 August 2017

Michael J Walker

5

1 reference

4 August 2017

Klaus F Rabe

7

1 reference

4 August 2017

Oscar E Della Pasqua

8

1 reference

4 August 2017

10 May 2006

1 reference

4 August 2017

1 reference

4 August 2017

7

1 reference

4 August 2017

74

1 reference

https://scigraph.springernature.com/pub.10.1186/1465-9921-7-74

4 August 2017

0 references

cites work

Cardiovascular disease in chronic obstructive pulmonary disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1481583

Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1481583

COPD exacerbations: the importance of a standard definition

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1481583

Exacerbations of chronic obstructive pulmonary disease.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1481583

Bacterial infections in patients requiring admission for an acute exacerbation of COPD; a 1-year prospective study

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1481583

COPD exacerbations: definitions and classifications.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1481583

Viral infections in obstructive airway diseases

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1481583

Chlamydia pneumoniae and COPD exacerbation.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1481583

Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1481583

Relationship between bacterial colonisation and the frequency, character, and severity of COPD exacerbations

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1481583

Exacerbations: etiology and pathophysiologic mechanisms

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1481583

Chronic obstructive pulmonary disease in the United Kingdom: trends in mortality, morbidity, and smoking

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1481583

Management of acute exacerbations of chronic obstructive pulmonary disease: a summary and appraisal of published evidence

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1481583

Recent trends in physician diagnosed COPD in women and men in the UK.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1481583

Toward a consensus definition for COPD exacerbations

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1481583

Relation of sputum inflammatory markers to symptoms and lung function changes in COPD exacerbations

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1481583

Effect of temperature on lung function and symptoms in chronic obstructive pulmonary disease

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1481583

Value of C-reactive protein measurements in exacerbations of chronic obstructive pulmonary disease.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1481583

Pulmonary gas exchange in acute respiratory failure.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1481583

Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1481583

Determinants of weaning and survival among patients with COPD who require mechanical ventilation for acute respiratory failure

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1481583

Determinants of immediate survival among chronic respiratory insufficiency patients admitted to an intensive care unit for acute respiratory failure. A prospective multicenter study. The French Task Group for Acute Respiratory Failure in Chronic Res

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1481583

Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease.

7 July 2018

1 reference

https://api.crossref.org/works/10.1186%2F1465-9921-7-74

Exacerbations and time spent outdoors in chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1465-9921-7-74

Exacerbations of Bronchitis: bronchial eosinophilia and gene expression for interleukin-4, interleukin-5, and eosinophil chemoattractants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1465-9921-7-74

Markers of inflammation and oxidative stress in exacerbated chronic obstructive pulmonary disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1465-9921-7-74

Disease severity and the effect of fluticasone propionate on chronic obstructive pulmonary disease exacerbations

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1465-9921-7-74

Outpatient oral prednisone after emergency treatment of chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1465-9921-7-74

Cost-effectiveness of fluticasone propionate in the treatment of chronic obstructive pulmonary disease: a double-blind randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1465-9921-7-74

Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1465-9921-7-74

Resource use and risk factors in high-cost exacerbations of COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1465-9921-7-74

Validation of general practitioner-diagnosed COPD in the UK General Practice Research Database

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1465-9921-7-74

Survival in COPD patients after regular use of fluticasone propionate and salmeterol in general practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1465-9921-7-74

The proportional Venn diagram of obstructive lung disease: two approximations from the United States and the United Kingdom.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1465-9921-7-74

Two-state mixed renewal processes for chronic disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1465-9921-7-74

Probabilistic Markov model to assess the cost-effectiveness of bronchodilator therapy in COPD patients in different countries.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1465-9921-7-74

Co-morbidity contributes to predict mortality of patients with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1465-9921-7-74

Supported discharge shortens hospital stay in patients hospitalized because of an exacerbation of COPD

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1465-9921-7-74

Bacteria and exacerbations of chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1465-9921-7-74

Outcomes following acute exacerbation of severe chronic obstructive lung disease. The SUPPORT investigators (Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments)

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1465-9921-7-74

Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1465-9921-7-74

Respiratory failure revisited: acute exacerbations of chronic bronchitis between 1961-68 and 1970-76

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1465-9921-7-74

Airway eosinophilia in chronic bronchitis during exacerbations

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1465-9921-7-74

Airway eosinophilia and expression of interleukin-5 protein in asthma and in exacerbations of chronic bronchitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1465-9921-7-74

Airway inflammation during stable and acutely exacerbated chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1465-9921-7-74

Risk factors for hospitalization for a chronic obstructive pulmonary disease exacerbation. EFRAM study

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1465-9921-7-74

Relationship between arterial blood gases and spirometry in acute exacerbations of chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1465-9921-7-74

Mechanisms of worsening gas exchange during acute exacerbations of chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1465-9921-7-74

Inhaled corticosteroids with/without long-acting beta-agonists reduce the risk of rehospitalization and death in COPD patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1465-9921-7-74

Modeling two-state disease processes with random effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1465-9921-7-74

Treatment of Acute Respiratory Acidosis in Chronic Obstructive Lung Disease

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/16686949

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Hospital and 1-year survival of patients admitted to intensive care units with acute exacerbation of chronic obstructive pulmonary disease

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/16686949

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Acute exacerbations of chronic obstructive pulmonary disease are accompanied by elevations of plasma fibrinogen and serum IL-6 levels

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/16686949

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1186/1465-9921-7-74

1 reference

Dimensions Publication ID

4 August 2017

0 references

1 reference

4 August 2017

1 reference